BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kang BW, Chau I. Molecular target: pan-AKT in gastric cancer. ESMO Open. 2020;5:e000728. [PMID: 32948630 DOI: 10.1136/esmoopen-2020-000728] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Yao L, Qu J, Liu L, Lu N, Wang J, Zhang J. Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression. J Transl Med 2021;19:325. [PMID: 34332586 DOI: 10.1186/s12967-021-03012-z] [Reference Citation Analysis]
2 Voutsadakis IA. The Landscape of PIK3CA Mutations in Colorectal Cancer. Clin Colorectal Cancer 2021;20:201-15. [PMID: 33744168 DOI: 10.1016/j.clcc.2021.02.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Voutsadakis IA. PI3KCA Mutations in Uterine Cervix Carcinoma. J Clin Med 2021;10:E220. [PMID: 33435133 DOI: 10.3390/jcm10020220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wang M, Wu Y, Yu W, Yu B, Ying H, Tsai F. Polyacetylenes from Codonopsis lanceolata Root Induced Apoptosis of Human Lung Adenocarcinoma Cells and Improved Lung Dysbiosis. BioMed Research International 2022;2022:1-15. [DOI: 10.1155/2022/7713355] [Reference Citation Analysis]
5 Xiao S, Zhou Y, Liu Q, Zhang T, Pan D. Identification of Pivotal MicroRNAs and Target Genes Associated with Persistent Atrial Fibrillation Based on Bioinformatics Analysis. Comput Math Methods Med 2021;2021:6680211. [PMID: 33747117 DOI: 10.1155/2021/6680211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liu D, Shi K, Fu M, Chen F. Placenta-specific protein 1 promotes cell proliferation via the AKT/GSK-3β/cyclin D1 signaling pathway in gastric cancer. IUBMB Life 2021;73:1131-41. [PMID: 34110086 DOI: 10.1002/iub.2514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fernandez CJ, George AS, Subrahmanyan NA, Pappachan JM. Epidemiological link between obesity, type 2 diabetes mellitus and cancer. World J Methodol 2021;11:23-45. [PMID: 34026577 DOI: 10.5662/wjm.v11.i3.23] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
8 Mortazavi M, Moosavi F, Martini M, Giovannetti E, Firuzi O. Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer. Crit Rev Oncol Hematol 2022;:103749. [PMID: 35728737 DOI: 10.1016/j.critrevonc.2022.103749] [Reference Citation Analysis]
9 Shiau J, Chuang Y, Cheng Y, Tang J, Hou M, Yen C, Chang H. Impacts of Oxidative Stress and PI3K/AKT/mTOR on Metabolism and the Future Direction of Investigating Fucoidan-Modulated Metabolism. Antioxidants 2022;11:911. [DOI: 10.3390/antiox11050911] [Reference Citation Analysis]
10 Zhong S, Zhang Z, Guo Z, Yang W, Dou G, Lv X, Wang X, Ge J, Wu B, Pan X, Wang H, Mou Y. Identification of novel natural inhibitors targeting AKT Serine/Threonine Kinase 1 (AKT1) by computational study. Bioengineered 2022;13:12003-20. [DOI: 10.1080/21655979.2021.2011631] [Reference Citation Analysis]
11 Xian Q, Zhu D, Zheng D. The Involvement of WDHD1 in the Occurrence of Esophageal Cancer as a Downstream Target of PI3K/AKT Pathway. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/5871188] [Reference Citation Analysis]
12 Wang Z, Zhang Q, Qi C, Bai Y, Zhao F, Chen H, Li Z, Wang X, Chen M, Gong J, Peng Z, Zhang X, Cai J, Chen S, Zhao X, Shen L, Li J. Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer. J Immunother Cancer 2022;10:e004703. [PMID: 35705314 DOI: 10.1136/jitc-2022-004703] [Reference Citation Analysis]